investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical Drug Development in Pancreatic Cancer

Udo Rudloff

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Duncan Jodrell

University of Cambridge

Cambridge, United Kingdom

Cancer Research UK (CRUK)

London, United Kingdom

Udo Rudloff

National Cancer Institute (NIH)

Rockville, United States

Related projects

Kenneth P Olive

Mechanisms of the Stromal Response to Smoothened Inhibition in Pancreatic Cancer

Pancreas

Pathology

Christine A Iacobuzio-Donahue

(PQB6) Genetics of Subclonal Evolution in Pancreatic Cancer

Pancreas

Pathology

Channing J Der

Biological Activity of Ras Oncogenes

Pancreas

Pathology

Maike Sander

A novel mouse model to identify biomarkers of IPMN formation and progression

Pancreas

Pathology

Ronald A Depinho

Genetics and Biology of Pancreatic Ductal Adenocarcinoma

Pancreas

Pathology

Keping Xie

Molecular Mediators of Pancreatic Cancer Invasion and Progression

Pancreas

Pathology

S P Hussain

Integrative Molecular Profiling of Human Pancreatic Cancer

Pancreas

Pathology

Kenneth W Gross

(Epi)Genomic Drivers of Primary and Metastatic Pancreatic Islet Cell Carcinoma

Pancreas

Pathology

Keping Xie

Functional Validation of Pancreatic Cancer Progression Biomarker

Pancreas

Pathology